Hjem › Hjernetumorer › Virginia
Kliniske studier for Hjernetumorer i Virginia
15 studier for Hjernetumorer søker deltakere på steder i Virginia.
Byer i Virginia
Offisiell studietekst (engelsk)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566C-SMART vs BE Well for Patients With Brain Tumors
- Virginia Commonwealth University, Richmond
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07224503Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NEXT Virginia, Fairfax
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05786924A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871FearLess in NeuroOncology
- Virginia Commonwealth University, Richmond
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06989086Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT05386108A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Inova Center for Personalized Health, Fairfax
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07428616A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Next Oncology -Virginia, Fairfax
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06136884Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- INOVA Health, Fairfax
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- University of Virginia Comprehensive Cancer Center, Charlottesville
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 21. jul. 2026 · NCT04348747Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
- University of Virginia, Charlottesville
RekruttererTidlig fase 1
Alder 18 til 65 · Alle kjønn · Oppdatert 4. mai 2026 · NCT06810336Sonodynamic Therapy in Patients With Recurrent GBM
- University of Virginia, Charlottesville
RekruttererFase 1
Alder 18 til 80 · Alle kjønn · Oppdatert 28. apr. 2026 · NCT06039709Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NEXT Virginia, Fairfax
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06810544S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. okt. 2025 · NCT03418961A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- NEXT Virginia, Fairfax
RekruttererFase 1/2
Alder 18 til 89 · Alle kjønn · Oppdatert 19. aug. 2025 · NCT06907043Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.